Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

2.1K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.1K
Allergic Reactions02:06

Allergic Reactions

31.9K
Overview
31.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

419
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel GATA2 Splice-Site Mutation Associated with Familial Myelodysplastic Syndrome.

Pediatric allergy, immunology, and pulmonology·2026
Same author

Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation.

Irish journal of medical science·2026
Same author

Is it time to focus on expiratory muscle training in children with asthma? A randomized controlled trial.

European journal of pediatrics·2026
Same author

PECU: A multicenter study on pediatric patients with cold-induced urticaria.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Influenza vaccination rates in children: a multicenter nationwide study.

The Turkish journal of pediatrics·2026
Same author

Homozygosity for rare or common hypomorphic <i>IL23R</i> variants confers a predisposition to tuberculosis in humans.

bioRxiv : the preprint server for biology·2026
Same journal

Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model.

ImmunoTargets and therapy·2026
Same journal

T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis.

ImmunoTargets and therapy·2026
Same journal

Irinotecan Modulates Immune Checkpoints in Neuroblastoma.

ImmunoTargets and therapy·2026
Same journal

Unveiling a ceRNA Network Involving IL-8 and TNF-α in Active Generalized Vitiligo by Multi-Omics Integration.

ImmunoTargets and therapy·2026
Same journal

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma.

ImmunoTargets and therapy·2026
Same journal

The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management.

ImmunoTargets and therapy·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.0K

Understanding and Managing Hyper IgE Syndromes.

Zeynep Meric1,2, Muhammed Aydin1,2, Dilan Demir Gumus1,2

  • 1Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Pediatric Allergy and Immunology, Istanbul, Turkey.

Immunotargets and Therapy
|November 11, 2025
PubMed
Summary
This summary is machine-generated.

Hyperimmunoglobulin E syndromes are diverse genetic disorders causing eczema, infections, and high IgE. Management focuses on controlling infections and improving quality of life for patients with these complex immune conditions.

Keywords:
STAT3Th2atopyeczemahyper IgE syndrome

More Related Videos

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.3K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.9K

Related Experiment Videos

Last Updated: Jan 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.0K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.3K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.9K

Area of Science:

  • Immunology
  • Genetics
  • Clinical Medicine

Background:

  • Hyperimmunoglobulin E (Hyper-IgE) syndromes are a heterogeneous group of disorders.
  • Characterized by eczema, recurrent infections, and elevated serum IgE levels.
  • Increasingly recognized with novel molecular defects complicating diagnosis.

Purpose of the Study:

  • To review current classifications of Hyper-IgE syndromes.
  • To summarize clinical and laboratory features.
  • To provide management perspectives.

Main Methods:

  • Literature review based on the International Union of Immunological Societies framework.
  • Synthesis of clinical and laboratory findings.
  • Analysis of management strategies.

Main Results:

  • Hyper-IgE syndromes exhibit significant genetic and clinical diversity.
  • Non-immunological manifestations, especially connective tissue issues, cause comorbidities.
  • Management requires controlling infections and preventing complications.

Conclusions:

  • Accurate classification is crucial for understanding Hyper-IgE syndromes.
  • Multifaceted management is essential for patient well-being.
  • Further research into genetic defects and non-immunological aspects is needed.